Clark Wealth Partners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-73
Closed -$4.58K 582
2026
Q1
$4.58K Sell
73
-12
-14% -$960 ﹤0.01% 348
2025
Q4
$8.11K Hold
85
﹤0.01% 268
2025
Q3
$8.11K Sell
85
-42
-33% -$4.35K ﹤0.01% 268
2025
Q2
$13.6K Buy
127
+18
+17% +$1.82K 0.01% 187
2025
Q1
$11K Hold
109
0.01% 195
2024
Q4
$9.74K Buy
+109
New +$9.6K 0.01% 176

Other funds holding BSX

Clark Wealth Partners's BSX Position: Q2 2026 in Review

Clark Wealth Partners sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 73 shares — an estimated $4.58K sold.

Clark Wealth Partners first reported a position in BSX in Q4 2024 and held it in 6 quarters. The position peaked at $13.6K in Q2 2025. 1,381 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Clark Wealth Partners reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Clark Wealth Partners sold 73 Boston Scientific shares in Q2 2026, an estimated $4.58K.
  • Clark Wealth Partners first reported a position in Boston Scientific in Q4 2024 and held it in 6 quarters.
  • Clark Wealth Partners's Boston Scientific position peaked at $13.6K in Q2 2025.
  • 1,381 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Clark Wealth Partners's 13F filing for Q2 2026, filed 28 Jul 2026.